Filter by:
HTAi 2022 Annual Meeting: Special Session – HTA in Challenging Times: Experience in Ukraine
Read Moreabout HTAi 2022 Annual Meeting: Special Session – HTA in Challenging Times: Experience in UkraineHTAi 2021 Annual Meeting – Keynote 3
Innovating Health Technology Assessment to Support Novel Interventions Dr Melanie Lee, CEO, LifeARC LifeArc’s CEO Dr Melanie Lee, PhD, CBE. Prior to joining LifeArc Melanie…
Read Moreabout HTAi 2021 Annual Meeting – Keynote 3
HTAi 2021 Annual Meeting – Keynote 1
Driving Innovation: the Regulator-HTA Partnership Dr June Raine CBE, Chief Executive, Medicines and Healthcare Products Regulatory Agency, UK Dr Raine trained in general medicine in…
Read Moreabout HTAi 2021 Annual Meeting – Keynote 1
HTAi 2021 Annual Meeting Keynote 2 – A Tale of Two Pandemics:
A tale of two pandemics: Neil Bertelsen, a HIV patient advocate reflects on the lessons learned from the HIV pandemic and asks why we are…
Read Moreabout HTAi 2021 Annual Meeting Keynote 2 – A Tale of Two Pandemics:
HTAi 2018 Annual Meeting – Key Note
Ms. Hannah Kettler Senior Program Office, Bill & Melinda Gates Foundation, USA Hannah Kettler, Ph.D., is a Senior Program Officer on the Life Sciences Partnerships…
Read Moreabout HTAi 2018 Annual Meeting – Key Note
HTAi 2022 Annual Meeting – Keynote
Keynote address by Prof. Marcel Levi Prof. Marcel Levi is an Internist and, since April 2021, the Chairman of the Netherlands Organization for Scientific Research…
Read Moreabout HTAi 2022 Annual Meeting – Keynote
HTAi Webinar: The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value
This HTAi Webinar is hosted by the HTAi Rare Diseases Interest Group. Evaluating the value of rare disease technologies poses challenges due to factors like…
Read Moreabout HTAi Webinar: The Characteristics of Rare Diseases That Complicate the Assessment of Technology Value
HTAi Webinar | Ethical analyses at HTA agencies: challenges and opportunities
Hosted by the HTAi Ethics Interest Group, this webinar discusses the challenges and opportunities for being involved in conducting ethical analyses at HTA agencies. Bart…
Read Moreabout HTAi Webinar | Ethical analyses at HTA agencies: challenges and opportunities
HTAi Webinar: Regulatory updates on harmonization of HTA among Medical Devices and Digital Medicine
On regulatory basis, the safety, performance, risks and benefits of medical devices are strongly regulated before market access. Strong regulation-based approach can create the impression…
Read Moreabout HTAi Webinar: Regulatory updates on harmonization of HTA among Medical Devices and Digital Medicine
HTAi Webinar | Evidence Based Searching for Health Technology Assessment Keeping up to Date with SuRe Info
Read Moreabout HTAi Webinar | Evidence Based Searching for Health Technology Assessment Keeping up to Date with SuRe InfoHTAi Webinar: Optimizing the Use of RWE in HTA Payer Decision Making
Read Moreabout HTAi Webinar: Optimizing the Use of RWE in HTA Payer Decision MakingHTAi Webinar: HTA Informing Innovative Drugs’ Market Access in LMICs
WHO identifies achieving Universal Health Coverage (UHC) as a strategic priority, which encompasses a full range of essential health services, of which technology constitutes a…
Read Moreabout HTAi Webinar: HTA Informing Innovative Drugs’ Market Access in LMICs